GLP-1 exerts its biological effects by binding to a specific receptor (GLP-1R), which is expressed in different types of peripheral tissues and in the central nervous system [12]
A lower 4-milligram dose still drove 19% weight loss
She's finally at a weight she feels comfortable with and each time she's tried to stop, the fear of putting the weight back on quickly becomes too great and she finds a reason to go back on the medication
Subsequently, in August 2025, semaglutide, a representative drug of GLP-1RAs, also obtained FDA approval, targeting the same indications as Resmetirom (8)
Looking for an Easier Way to Stay on Track While Taking a GLP-1
Ivanievi M, Herman M, Horvatiek M, Vui Lovreni M, elmi J